Network origin in Stewart A. Low first degree
Entity | Entity type | Industry | |
---|---|---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stewart A. Low via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Biotechnology | Director/Board Member Founder | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Biotechnology | Director/Board Member Founder | |
QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
DePauw University | College/University | Undergraduate Degree | |
University of New England (Australia) | College/University | Masters Business Admin | |
The University of Western Australia | College/University | Doctorate Degree | |
University of Warwick | College/University | Doctorate Degree | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ReElement Technologies LLC
ReElement Technologies LLC Other Metals/MineralsNon-Energy Minerals Part of American Resources Corp. (Indiana), ReElement Technologies LLC is a company that focuses on redefining how critical and rare earth elements are sourced and processed. The company is based in Fishers, IN. The company has developed its innovative and scalable "capture-process-purify" process chain in conjunction with its licensed intellectual property including 16 patents and technologies and sponsored research partnerships with three leading universities to support the domestic supply chains growing demand for magnet and battery metals. ReElement Technologies is committed to recycling end-of-life products such as rare earth permanent magnets and lithium-ion batteries, as well as coal-based waste streams and byproducts to create a low-cost and environmentally-safe, circular supply chain. The CEO of the company is Mark C. Jensen. | Other Metals/Minerals | Director/Board Member | |
State of Indiana | Province/State | Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin | |
Purdue Research Foundation
Purdue Research Foundation Miscellaneous Commercial ServicesCommercial Services Purdue Research Foundation manages and licenses intellectual property, administers trusts, acquires property, negotiates research contracts and performs other services. The organization was founded in 1930 and is headquartered in West Lafayette, IN. | Miscellaneous Commercial Services | Chief Executive Officer | |
AMERICAN RESOURCES CORPORATION | Coal | Director/Board Member | |
Hasler Ventures LLC | Founder | ||
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Eradivir, Inc.
Eradivir, Inc. BiotechnologyHealth Technology Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low. | Biotechnology | Founder | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Founder | |
University of California San Diego | College/University | Doctorate Degree | |
Brigham Young University | College/University | Undergraduate Degree | |
Purdue University | College/University | Corporate Officer/Principal | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor | |
University of Salford | College/University | Graduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member | |
Stoicheia, Inc.
Stoicheia, Inc. Miscellaneous Commercial ServicesCommercial Services Stoicheia, Inc. is a company based in Suite 330, IL that specializes in digital materials discovery. Stoicheia uses a combination of proprietary AI and high-throughput screening technology to discover new materials that impact industries such as automotive, chemical, oil, and clean energy. The company has access to the world's largest combinatorial material libraries and uses proprietary nanocombinatoricstm and megalibrarytm platforms to enable the discovery of new materials with properties driving the development of the renewable and net-zero economy. The company was founded by Chad A. Mirkin and Andrey Ivankin, and Jeff Erhardt has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
NVasc, Inc.
NVasc, Inc. Medical SpecialtiesHealth Technology NVasc, Inc. is an early-stage ophthalmology company founded in February 2019 and funded by Kairos Ventures in November 2019. The company is based in Atherton, CA. The company is focused on treating the leading causes of blindness through choroidal and retinal revascularization. The company is planning to manufacture NVB001 that can be used in toxicokinetic studies and in early clinical trials in humans. NVasc has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases. | Medical Specialties | Director/Board Member | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member | |
Vivodyne, Inc.
Vivodyne, Inc. Packaged SoftwareTechnology Services Vivodyne, Inc. is a biotechnology company based in Philadelphia, PA. Vivodyne accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time. The company uses robots to grow and experiment on lab-grown human organs at a massive scale, creating datasets of unparalleled realism and breadth to power a predictive AI platform technology. Vivodyne's platform powers the entire discovery pipeline by testing drugs on thousands of lab-grown human tissues with complete robotic automation, accelerating the discovery of cures to human diseases by creating predictive, preclinical human data. The company was founded by Andrei Georgescu and Dan Huh, with Andrei Georgescu serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
Kapteyn-Murnane Laboratories, Inc.
Kapteyn-Murnane Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Kapteyn-Murnane Laboratories, Inc. manufactures laser and amplified systems and fiber lasers. Its products include extreme ultraviolet sources, vacuum ultraviolet source, integrated systems, ultrafast TI:s laser, fiber lasers and measurement products. The company was founded by Henry C. Kapteyn and Margaret M. Murnane in November 1994 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member | |
SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member | |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Doctorate Degree | |
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EMYRIA LIMITED | Packaged Software | Director/Board Member | |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Pharmaceuticals: Major | Director/Board Member | |
Eliminate Cancer, Inc. | Chief Executive Officer | ||
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
United States | 41 |
Australia | 4 |
United Kingdom | 3 |
Canada | 3 |
Ireland | 2 |
Sectoral
Health Technology | 23 |
Consumer Services | 11 |
Commercial Services | 7 |
Government | 3 |
Finance | 3 |
Operational
Director/Board Member | 68 |
Corporate Officer/Principal | 24 |
Independent Dir/Board Member | 13 |
Founder | 10 |
Chief Tech/Sci/R&D Officer | 9 |
Most connected contacts
Insiders | |
---|---|
Franklyn Prendergast | 43 |
Karen Smith | 30 |
William J. Rutter | 22 |
Daniel Hasler | 11 |
Philip Low | 10 |
Alex Andrianopoulos | 7 |
- Stock Market
- Insiders
- Stewart A. Low
- Company connections